Greenwich, Connecticut-based W. R. Berkley Corporation (WRB) is an insurance holding company, operating as a commercial line writer worldwide. With a market cap of $26.7 billion, the company operates through Insurance and Reinsurance & Monoline Excess segments.

W. R. Berkley has significantly outperformed the broader market over the past year and in 2025. WRB stock has soared 24.7% over the past 52 weeks and 22.3% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 14.3% gains over the past year and 9% returns in 2025.

Narrowing the focus, WRB has also outperformed the sector-focused Financial Select Sector SPDR Fund’s (XLF) 19.5% surge over the past 52 weeks and 8.8% uptick in 2025.

W. R. Berkley’s stock prices gained 1.1% in the trading session following the release of its better-than-expected Q2 results on Jul. 21. The insurer reported a solid 10.8% year-over-year growth in total revenues, reaching $3.7 billion and exceeding the Street expectations by 1.8%. This was supported by a solid growth in premiums, with its net premiums written coming in at a record $3.4 billion. Meanwhile, its adjusted EPS inched up 2.9% year-over-year to $1.05, surpassing the consensus estimates by 1.9%.

For the full fiscal 2025, ending in December, analysts expect WRB to report an adjusted EPS of $4.22, up 1.9% year-over-year. On a more positive note, the company has a solid earnings surprise history. It has met or surpassed the Street’s bottom-line estimates in each of the past four quarters.

W. R. Berkley has a consensus “Moderate Buy” rating overall. Of the 18 analysts covering the stock, opinions include six “Strong Buys,” 11 “Holds,” and one “Strong Sell.”

This configuration is slightly less optimistic than three months ago, when seven analysts gave “Strong Buy” recommendations.

On Jul. 22, Wells Fargo (WFC) analyst Elyse Greenspan maintained an “Equal-Weight” rating on WRB and lowered the price target from $71 to $68.

As of writing, WRB’s mean price target of $73.75 represents a modest 3.1% premium to current price levels. Meanwhile, the street-high target of $86 suggests a 20.2% upside potential.